Adrian Heath, from Knutton, had a knife held to his throat after being lured overseas by criminals posing as football ...

(MENAFN- GetNews) The Key KRAS Inhibitors Companies in the market include - Pfizer, Roche/Chugai/Genentech, Revolution Medicines, Eli Lilly and Company, Merck, Taiho ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for therapeutics. Among them, the Y220C mutation is the ninth most frequent and it ...

The treatment of patients with blood cancers has undergone a radical transformation over the last couple of decades, with survival rates for some leukaemias and lymphomas increasing greatly. Diseases ...

Merck begins phase 3 KANDLELIT-007 trial of calderasib in combo Keytruda QLEX in certain patients with advanced NSCLC: Rahway, New Jersey Friday, January 9, 2026, 15:00 Hrs [IST] ...

Professor Paul Workman has been awarded an OBE (Officer of the Order of the British Empire) in the New Year Honours list 2026 for services to cancer research. Previously Chief Executive and President ...

Andrea Schievella, Head of Business Development (US), Tel: +44 20 3469 6653, Email: andrea.schievella@cancer.org.uk; George Tzircotis, Associate Director Business ...

The new Phase III study will test calderasib in a chemo-free regimen for G12C-mutated patients regardless of PD-L1 status.

“Any viewer’s tongue will grow shorter trying to describe it,” marveled the inveterate traveler Ibn Battuta while visiting Jerusalem in 1326. “This is one of the most fantastic of all buildings, of ...

Immerse yourself in the most compelling and consequential stories from around the globe. The world is changing in big ways every day. State of the World from NPR takes you where the news is happening ...

From Clarence House to Windsor Castle, and Meghan Markle to the Queen, Newsweek's new podcast The Royal Report brings you all the news you want from the palace and beyond. Hosted by Newsweek royal ...